Zydus receives final approvals from the USFDA for Phytonadione Tablets and Colchicine Tablets

Deepthi | Myequity news | Date : 21-02-2019 13:50:00 IST

Zydus Cadila has received the final approval from the USFDA to market Phytonadione Tablets USP (US RLD—Mephyton), 5mg. Phytonadione is Vitamin K1 and is used to treat & prevent low levels of blood clotting factors that the body naturally produces. These substances help in thickening of the blood and stop the bleeding normally.

The group also received the final approval for Colchicine Tablets USP (USRLD—Colcrys), 0.6mg. Colchicineis used to prevent or treat attacks of gout (also called gouty arthritis). This condition is caused by high uric acid levels in the blood. An attack of gout occurs when uric acid causes inflammation (pain, redness and swelling) in a joint. This medication is also used to prevent attacks of pain in the abdomen, chest or joints caused by a genetic auto-inflammatory disease called as familial Mediterranean fever.


More from Myequity